Page last updated: 2024-12-07

dithiobis(succinimidylpropionate)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dithiobis(succinimidylpropionate) (DSP) is a homobifunctional crosslinker that is widely used in biochemistry and molecular biology. It is a water-soluble reagent that reacts with primary amines, such as those found in proteins and peptides. The reagent contains two succinimidyl esters that react with primary amines to form stable amide bonds. This reaction is typically carried out in an aqueous buffer at a pH of 7.0-8.0. DSP is used to crosslink proteins, peptides, and other molecules, as well as to modify the properties of proteins and peptides. DSP crosslinking can be used to study protein-protein interactions, to stabilize protein structures, to create new protein conjugates, and to immobilize proteins on solid supports. The reagent can also be used to label proteins with fluorescent probes. DSP is a useful tool for a variety of biochemical and molecular biological applications. The use of DSP for the study of protein-protein interactions is based on the principle that the crosslinking of two proteins can be used to identify and characterize protein complexes. The crosslinking of proteins can be used to stabilize protein structures and to prevent their degradation. The reagent can also be used to create new protein conjugates with desired properties, such as increased stability or new catalytic activity. DSP can also be used to immobilize proteins on solid supports for the development of biosensors and other analytical devices. The reagent has been used to study the structure and function of a wide variety of proteins, including enzymes, receptors, and antibodies.'

dithiobis(succinimidylpropionate): used to study interactions of structural proteins; RN given refers to unlabeled cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93313
SCHEMBL ID43720
MeSH IDM0057379

Synonyms (59)

Synonym
(2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxo-propyl]disulfanyl]propanoate
1-((3-((3-((2,5-dioxo-1-pyrrolidinyl)oxy)-3-oxopropyl)dithio)propanoyl)oxy)-2,5-pyrrolidinedione
57757-57-0
nsc328386
nsc-328386
3,3'-dithiodipropionic acid di(n-hydroxysuccinimide ester), powder
lomant's reagent
dithiobis(succinimidylpropionate)
2,5-pyrrolidinedione, 1,1'-(dithiobis((1-oxo-3,1-propanediyl)oxy))bis-
1,1'-{-disulphanediylbis[(1-oxopropane-3,1-diyl)oxy]}dipyrrolidine-2,5-dione
FXYPGCIGRDZWNR-UHFFFAOYSA-N
1,1'-{disulphanediylbis[(1-oxopropane-3,1-diyl)oxy]}dipyrrolidine-2,5-dione
di(n-succinimidyl) 3,3'-dithiodipropionate
dtsp
3,3'-dithiodipropionic acid di(n-succinimidyl ester)
3,3'-dithiodipropionic acid bis(n-succinimidyl ester)
(2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoate
3,3'-dithiodipropionic acid di(n-hydroxysuccinimide ester)
evy5d0u6sh ,
unii-evy5d0u6sh
einecs 260-931-5
nsc 328386
disuccinimido dithiobispropionate
FT-0625369
AKOS015894391
2,5-dioxopyrrolidin-1-yl 3-({3-[(2,5-dioxopyrrolidin-1-yl)oxy]-3-oxopropyl}disulfanyl)propanoate
dithiobis(succinimidyl propionate)
bis(2,5-dioxopyrrolidin-1-yl) 3,3'-disulfanediyldipropanoate
SCHEMBL43720
dsp crosslinker
BP-22658
2,5-pyrrolidinedione, 1,1'-[dithiobis[(1-oxo-3,1-propanediyl)oxy]]bis-
3,3'-dithiobis(succinimidyl propionate)
3,3'-dithiobis(n-hydroxysuccinimidylpropionate)
propanoic acid, 3,3'-dithiobis-, 1,1'-bis(2,5-dioxo-1-pyrrolidinyl) ester
3,3'-dithioldipropionic acid bis(n-hydroxysuccinimide ester)
3,3'-dithio(succinimidyl propionate)
bis(2-((succinimidyloxy)carbonyl)ethyl) disulfide
DTXSID00206449
mfcd00042045
3,3'-dithiopropionic acid di(n-succinimidyl ester)
GS-5670
3,3'-dithiodipropionic acid di(n-hydroxysuccinimide ester), >=97.0% (hplc)
dithiobis[succinimidyl propionate]
di(n-succinimidyl) 3,3-dithiodipropionate [cross-linking reagent]
(dtsp);dithio-bis-succinimidyl propionate
F11350
CS-0068460
di(n-succinimidyl)3,3-dithiodipropionate[cross-linkingreagent]
AMY38463
Q27277388
benzene, 1-fluoro-2-(2,2,2-triethoxyethyl)-
HY-118759
LCWG014
di(n-succinimidyl) 3,3'-dithiodipropionate; dithiobis(succinimidyl propionate);di(n-succinimidyl) 3,3'-dithiodipropionate [cross-linking reagent]
A869597
S0626
SY052172
di(n-succinimidyl) 3,3 inverted exclamation mark -dithiodipropionate [cross-linking reagent]

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In dose-response curves the extent of the cytoskeletal association appears to follow the extent of bridging, continuing to increase beyond where stimulated degranulation is maximal."( Cross-linking of immunoglobulin E-receptor complexes induces their interaction with the cytoskeleton of rat basophilic leukemia cells.
Baird, B; Holowka, D; Robertson, D, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (211)

TimeframeStudies, This Drug (%)All Drugs %
pre-199077 (36.49)18.7374
1990's73 (34.60)18.2507
2000's30 (14.22)29.6817
2010's27 (12.80)24.3611
2020's4 (1.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.73 (24.57)
Research Supply Index5.37 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index38.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other214 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]